chr10-22714296-C-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005028.5(PIP4K2A):āc.31G>Cā(p.Val11Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,611,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_005028.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PIP4K2A | NM_005028.5 | c.31G>C | p.Val11Leu | missense_variant | 1/10 | ENST00000376573.9 | NP_005019.2 | |
PIP4K2A | XM_006717450.3 | c.31G>C | p.Val11Leu | missense_variant | 1/9 | XP_006717513.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PIP4K2A | ENST00000376573.9 | c.31G>C | p.Val11Leu | missense_variant | 1/10 | 1 | NM_005028.5 | ENSP00000365757 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151856Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000483 AC: 12AN: 248514Hom.: 0 AF XY: 0.0000594 AC XY: 8AN XY: 134652
GnomAD4 exome AF: 0.0000343 AC: 50AN: 1459332Hom.: 0 Cov.: 30 AF XY: 0.0000413 AC XY: 30AN XY: 726080
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151856Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74168
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 27, 2022 | The c.31G>C (p.V11L) alteration is located in exon 1 (coding exon 1) of the PIP4K2A gene. This alteration results from a G to C substitution at nucleotide position 31, causing the valine (V) at amino acid position 11 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at